Message from the President

As a leading global Contract Research Organization (CRO), we are dedicated to providing full-service and functional solutions across the entire development lifecycle for pharmaceutical, biotechnology, medical device, and consumer product companies locally and globally.

Dated back to 1995, we have employed more than 4,000 dedicated professionals in 30 different countries across Asia, Europe and North America around the world through its organic growth and strategic acquisitions over the past 25+ years. We have been highly recognized by the industry with our full-service capabilities, high quality of service as well as mature & standardized operation system. Up till now, we have accomplished over 1,500 full-service clinical studies, covering all clinical trial phases and major therapeutic areas. Additionally, we have continued to expand our presence in the biotech sector.
We have partnered with 500+ emerging biopharmaceutical companies worldwide.

Looking ahead, by leveraging our global presence and full-service capabilities, we will continue expanding our geographic coverage and capabilities, exploring innovative service offerings & new business, accelerating commercialization and joining hands with partners to contribute our efforts to a healthier and safer world.

Global Chairman and CEO

Ling Zhen